MarleyE, WozniakKM. Interactions of a non-selective monoamine oxidase inhibitor, phenelzine, with inhibitors of 5-hydroxytryptamine, dopamine or noradrenaline re-uptake. J Psychiatr Res1984; 2: 173–189.
2.
AranowRB, HudsonJI, PopeHG, Elevated antidepressant plasma levels after addition of fluoxetine. Am J Psychiatry1989; 146: 911–913.
3.
BellIR, ColeJO. Fluoxetine induces elevation of desipramine level and exacerbation of geriatric nonpsychotic depression (letter). J Clin Psychopharmacol1988; 8: 447–448.
4.
GoodnickPJ. Influence of fluoxetine on plasma levels of desipramine (letter). Am J Psychiatry1989; 146: 552.
5.
BenfieldP, HeelRC, LewisSP. Fluoxetine: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depressive illness. Drugs1986; 32: 481–508.
